CRISPR技術の世界市場レポート 2024

CRISPR技術の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には22.9%の年間複合成長率（CAGR）で46億5,000万米ドルに成長すると予想されます。予想される成長は、遺伝子治療薬の需要増加、ゲノム編集技術の進歩、創薬ニーズの高まり、診断や農業におけるCRISPR応用の拡大、CRISPR技術採用の急増にかかっています。主な動向には、革新的な技術開発、創薬のための強化されたCRISPR、AI支援による正確な遺伝子編集、idmseqなどの精度向上アプローチへの投資、コラボレーション、ライセンシング契約が含まれます。

診断ツールとしてのCRISPR技術の採用により、市場の軌道が向上します。特に、Sherlock CRISPR SARS-CoV-2キットは、感染症、特にCOVID-19に対してCRISPR技術を採用した初の診断キットとして際立っています。 2021年2月、FDAはSherlock BioSciences Inc.のCRISPRベースのSHERLOCK（Specific High-sensitivity Enzymatic Reporter unLOCKing）診断検査に緊急使用許可を与えました。このキットは高い特異性と感度を示し、さまざまな検体からSARS-CoV-2ウイルスのRNAまたはDNA配列を正確にターゲットします。偽陰性または偽陽性を回避する信頼性により、CRISPR技術は感染症診断における重要な役割を果たし、CRISPR製品およびサービスの需要の急増を促進します。

CRISPR技術市場は、進行中の臨床試験の数の増加によって大幅な成長が見込まれています。新しい医療介入の安全性と有効性を評価する上で極めて重要な臨床試験では、強力な遺伝子編集ツールとしてCRISPR技術がますます活用されています。がん治療、血液疾患、遺伝性眼疾患、感染症にわたるさまざまな試験により、CRISPRの多用途性と可能性が強調されています。特に、2023年 2月の時点で、世界保健機関は米国での臨床試験が大幅に増加し、2022年には168,520件に達し、9,901件の増加であると報告しています。この臨床試験の急増は、医学調査と治療方法論の進歩においてCRISPR技術の役割が急速に増大していることを浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のCRISPR技術市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• デザインツール
• プラスミドとベクター
• Cas9とG-RNA
• デリバリーシステム製品
• 世界のCRISPR技術市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ゲノム編集・遺伝子工学
• 遺伝子組み換え生物
• 農業バイオテクノロジー
• その他の用途
• 世界のCRISPR技術市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• インダストリアルバイオテクノロジー
• 生物学的調査
• 農業調査
• 治療と創薬

第7章 地域および国の分析

• 世界のCRISPR技術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のCRISPR技術市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• CRISPR技術市場の競合情勢
• CRISPR技術市場の企業プロファイル
  • Crispr Therapeutics
  • Thermo Fisher Scientific
  • Intellia Therapeutics
  • Horizon Discovery
  • Synthego Corporation

第31章 その他の大手および革新的な企業

• Integrated DNA Technology（Danaher）
• Editas Medicine
• GenScript
• Agilent Technologies
• New England Biolabs
• CSIR-Institute of Genomics &Integrative Biology（IGIB）
• Strand Life Sciences Pvt. Ltd.
• Bio Palette Co. Ltd.
• CSL Limited
• C4U Co. Ltd.
• BGI Group
• Churchi Genome Engineering and Therapeutic Research Center.
• Beam Therapeutics Inc.
• Eurofins Genomics India
• Setsurotech Co. Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

CRISPR is a gene-editing technology enabling researchers to modify DNA sequences, effectively altering gene function and genetic information.

The primary product categories in CRISPR technology include design tools, plasmids and vectors, CAS9 and G-RNA components, and delivery systems. CRISPR-Cas9 is an innovative tool allowing scientists to edit specific genome sections by adding, removing, or altering DNA sequences. Applications encompass genome editing, genetic engineering, agricultural biotechnology, among others, and find utility across various sectors including industrial biotech, biological and agricultural research, therapeutics, and drug discovery.

The CRISPR technology market research report is one of a series of new reports from The Business Research Company that provides CRISPR technology market statistics, including CRISPR technology industry global market size, regional shares, competitors with a CRISPR technology market share, detailed CRISPR technology market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR technology industry. This CRISPR technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crispr technology market size has grown exponentially in recent years. It will grow from $1.64 billion in 2023 to $2.04 billion in 2024 at a compound annual growth rate (CAGR) of 24.1%. Historical growth can be attributed to the increase in funding and a rise in pharmaceutical research and development (R&D) expenditure.

The crispr technology market size is expected to see exponential growth in the next few years. It will grow to $4.65 billion in 2028 at a compound annual growth rate (CAGR) of 22.9%. The anticipated growth hinges on increased demand for gene therapeutics, advancements in genome editing technology, rising needs in drug discovery, expanded applications of CRISPR in diagnostics and agriculture, coupled with a surge in CRISPR technology adoption. Major trends involve innovative technology development, enhanced CRISPR for drug discovery, AI-assisted precise gene editing, investments in accuracy-improving approaches such as idmseq, collaborations, and licensing agreements.

The adoption of CRISPR technology as a diagnostic tool is poised to elevate the market's trajectory. Notably, the Sherlock CRISPR SARS-CoV-2 kit stands out as the inaugural diagnostic kit employing CRISPR technology for infectious diseases, particularly COVID-19. In February 2021, the FDA granted emergency use authorization to Sherlock BioSciences Inc.'s CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) diagnostic test. This kit exhibits high specificity and sensitivity, targeting RNA or DNA sequences of the SARS-CoV-2 virus with precision from various specimens. Its reliability in avoiding false negatives or positives positions CRISPR technology as a pivotal player in infectious disease diagnosis, fostering a surge in demand for CRISPR products and services.

The CRISPR technology market is set to witness substantial growth propelled by the escalating number of ongoing clinical trials. Clinical trials, pivotal in assessing the safety and efficacy of new medical interventions, are increasingly leveraging CRISPR technology as a potent gene-editing tool. Various trials, spanning cancer treatment, blood disorders, inherited eye diseases, and infectious diseases, underscore CRISPR's versatility and potential. Notably, as of February 2023, the World Health Organization reports a significant uptick in clinical trials in the US, reaching 168,520 in 2022-an increase of 9,901 trials. This surge in clinical trials underscores the burgeoning role of CRISPR technology in advancing medical research and treatment methodologies.

Key players in the CRISPR technology market are strategically focusing on the development of innovative products, specifically tailored CRISPR solutions, to enhance their service offerings. Dedicated CRISPR products refer to specialized tools and reagents designed exclusively for CRISPR gene editing applications. Illustratively, QIAGEN NV, a Germany-based leader in sample and assay technologies, introduced the QIAprep & CRISPR Kit and CRISPR Q-Primer Solutions in June 2021. These products offer an all-in-one, sensitive method for detecting knock-ins resulting from small insertions during gene editing and knockouts generated from guide RNA (gRNA). The incorporation of the Sanger DNA sequencing method, along with downstream PCR detection, coupled with liquid-based sample preparation, distinguishes these kits and solutions.

In March 2021, Integrated DNA Technologies (IDT), a prominent genomics solutions provider based in the United States, successfully acquired Swift Biosciences. This strategic acquisition is aimed at capitalizing on Swift Biosciences' expertise in academic and clinical research related to Next-Generation Sequencing (NGS). Swift Biosciences, based in the U.S., is recognized for its contributions to the development of genomics kits specifically designed for preparing NGS libraries. This strategic move reinforces the commitment of major companies to expanding their product portfolios and staying at the forefront of technological advancements in the CRISPR technology market.

Major companies operating in the crispr technology market report are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd., Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Horizon Discovery Group, Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

North America was the largest region in the CRISPR technology market in 2023. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the crispr technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the crispr technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The CRISPR technology market includes revenue earned by CRISPR Screening Libraries, CRISPR Positive Controls, CRISPR Negative Controls, and Gene-specific Knockout Kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on CRISPR technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for CRISPR technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CRISPR technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Design Tools; Plasmid And Vector; Cas9 And G-RNA; Delivery System Products
• 2) By Application: Biomedical; Agriculture; Diagnostics; Other Applications
• 3) By End-User: Academic Research Organizations; Biopharmaceutical Companies; Agricultural Biotechnology Companies; Contract Research Organizations (CROs)
• Companies Mentioned: Crispr Therapeutics; Thermo Fisher Scientific; Intellia Therapeutics; Horizon Discovery; Synthego Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CRISPR Technology Market Characteristics

3. CRISPR Technology Market Trends And Strategies

4. CRISPR Technology Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global CRISPR Technology Market Size and Growth

• 5.1. Global CRISPR Technology Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global CRISPR Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global CRISPR Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. CRISPR Technology Market Segmentation

• 6.1. Global CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Design Tools
• Plasmid And Vector
• Cas9 And G-RNA
• Delivery System Products
• 6.2. Global CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Genome Editing/ Genetic Engineering
• Genetically Modified Organisms
• Agricultural Biotechnology
• Other Applications
• 6.3. Global CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Industrial Biotech
• Biological Research
• Agricultural Research
• Therapeutics And Drug Discovery

7. CRISPR Technology Market Regional And Country Analysis

• 7.1. Global CRISPR Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global CRISPR Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific CRISPR Technology Market

• 8.1. Asia-Pacific CRISPR Technology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China CRISPR Technology Market

• 9.1. China CRISPR Technology Market Overview
• 9.2. China CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India CRISPR Technology Market

• 10.1. India CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan CRISPR Technology Market

• 11.1. Japan CRISPR Technology Market Overview
• 11.2. Japan CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia CRISPR Technology Market

• 12.1. Australia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia CRISPR Technology Market

• 13.1. Indonesia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea CRISPR Technology Market

• 14.1. South Korea CRISPR Technology Market Overview
• 14.2. South Korea CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe CRISPR Technology Market

• 15.1. Western Europe CRISPR Technology Market Overview
• 15.2. Western Europe CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK CRISPR Technology Market

• 16.1. UK CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany CRISPR Technology Market

• 17.1. Germany CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France CRISPR Technology Market

• 18.1. France CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy CRISPR Technology Market

• 19.1. Italy CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain CRISPR Technology Market

• 20.1. Spain CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe CRISPR Technology Market

• 21.1. Eastern Europe CRISPR Technology Market Overview
• 21.2. Eastern Europe CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia CRISPR Technology Market

• 22.1. Russia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America CRISPR Technology Market

• 23.1. North America CRISPR Technology Market Overview
• 23.2. North America CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA CRISPR Technology Market

• 24.1. USA CRISPR Technology Market Overview
• 24.2. USA CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada CRISPR Technology Market

• 25.1. Canada CRISPR Technology Market Overview
• 25.2. Canada CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America CRISPR Technology Market

• 26.1. South America CRISPR Technology Market Overview
• 26.2. South America CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil CRISPR Technology Market

• 27.1. Brazil CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East CRISPR Technology Market

• 28.1. Middle East CRISPR Technology Market Overview
• 28.2. Middle East CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa CRISPR Technology Market

• 29.1. Africa CRISPR Technology Market Overview
• 29.2. Africa CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. CRISPR Technology Market Competitive Landscape And Company Profiles

• 30.1. CRISPR Technology Market Competitive Landscape
• 30.2. CRISPR Technology Market Company Profiles
  • 30.2.1. Crispr Therapeutics
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Intellia Therapeutics
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Horizon Discovery
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Synthego Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. CRISPR Technology Market Other Major And Innovative Companies

• 31.1. Integrated DNA Technology (Danaher)
• 31.2. Editas Medicine
• 31.3. GenScript
• 31.4. Agilent Technologies
• 31.5. New England Biolabs
• 31.6. CSIR-Institute of Genomics & Integrative Biology (IGIB)
• 31.7. Strand Life Sciences Pvt. Ltd.
• 31.8. Bio Palette Co. Ltd.
• 31.9. CSL Limited
• 31.10. C4U Co. Ltd.
• 31.11. BGI Group
• 31.12. Churchi Genome Engineering and Therapeutic Research Center.
• 31.13. Beam Therapeutics Inc.
• 31.14. Eurofins Genomics India
• 31.15. Setsurotech Co. Ltd

32. Global CRISPR Technology Market Competitive Benchmarking

33. Global CRISPR Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The CRISPR Technology Market

35. CRISPR Technology Market Future Outlook and Potential Analysis

• 35.1 CRISPR Technology Market In 2028 - Countries Offering Most New Opportunities
• 35.2 CRISPR Technology Market In 2028 - Segments Offering Most New Opportunities
• 35.3 CRISPR Technology Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer